MobiDiag, now part of Hologic Inc., specializes in advanced diagnostic technologies aimed at enhancing healthcare outcomes. One of their key innovations is the Novodiag® System, which utilizes high multiplex technology. This system is designed for simplicity, accuracy, and affordability, enabling the detection of a wide range of pathogens through high-multiplex and targeted assays. The precision engineering of the Novodiag® System allows for efficient testing, which is crucial in the timely diagnosis and treatment of various medical conditions.

The integration of MobiDiag into Hologic Inc. underscores a commitment to improving women's health through innovative medical technologies. Hologic, as a global leader in medical technology, focuses on early detection and treatment, aligning with MobiDiag's mission to enhance healthcare accessibility and effectiveness. The combination of MobiDiag's diagnostic capabilities with Hologic's resources and expertise positions the company to make significant advancements in the field of medical diagnostics.

Finland

Mobidiag is a biotechnology company specializing in developing and marketing novel, innovative solutions for molecular diagnostics of infectious diseases.COVID-19: Received Emergency Use Authorization in Finland for its Amplidiag COVID-19 real-time PCR

MobiDiag

Company Details